BLIS Technologies reports slight revenue increase, profitability hit

BLIS Technologies has reported a slight increase in revenue for the first quarter of the 2025-26 financial year, but said one-off cost pressures have impacted profitability.

The company, which manufactures advanced probiotic strains, achieved revenue of $3.5 million for the quarter, up from $3.4m in the same period last year.

However, its ebitda was a loss of $200,000, compared to a profit of $500,000 in the first quarter of the previous financial year.

BLIS attributed the decline in ebitda to one-off cost increases in the supply chain, which it expects to amount to $900,000 for the full year.

The company said the higher costs had a $700,000 impact on the first-quarter result.

BLIS Technologies said it is forecasting revenue of around $7.5m for the first half of the financial year, driven by stronger ingredient revenues.

This represents a 25% increase from the same period last year.

However, it expects ebitda, including one-off costs, for the first half of the year to be slightly below the previous year.

The company said it is still anticipating revenue growth of 10% to 15% for the entire financial year.